minttore.blogg.se - Ga 68 netspot

GA 68 NETSPOT FULL
GA 68 NETSPOT PROFESSIONAL

You will be exposed to radiation while you receive this medicine.Your doctor may tell you to stop breastfeeding, and pump and discard your breast milk for at least 12 hours after you receive this medicine.

Tell your doctor if you are pregnant, or if you have other medical problems.

Tell your doctor if you are using somatostatin analogs or steroid medicines.

Some medicines can affect how gallium Ga 68 dotatate works.

This will help remove this radioactive medicine from your body.ĭrugs and Foods to Avoid: Ask your doctor or pharmacist before using any other medicine, including over-the-counter medicines, vitamins, and herbal products.

Drink and urinate as often as possible during the first hours after the scan.

Drink enough water to be hydrated before the PET scan.

It is given through a needle placed in one of your veins just before you have a PET scan.

GA 68 NETSPOT PROFESSIONAL

A doctor or other trained health professional will give you this medicine.You should not receive it if you had an allergic reaction to gallium Ga 68 dotatate. When This Medicine Should Not Be Used: This medicine is not right for everyone. Brand Name(s): NetspotThere may be other brand names for this medicine.

GA 68 NETSPOT FULL

NETSPOT Full U.S.Gallium ga 68 dotatate (By injection) Gallium Ga 68 Dotatate (GAL-ee-um Ga 68 DOE-ta-tate) Given just before a PET scan (positron emission tomography) for localization of somatostatin receptor positive neuroendocrine tumors. Please contact us at 95 for further details. This product has been designated as an orphan drug by the EMA and the FDA. NETSPOT™ is a novel patented kit developed by AAA for the preparation of gallium Ga 68 dotatate for injection, for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients using Positron Emission Tomography (“PET“). NETSPOT™ is a significant improvement over existing diagnostic tools and will enable us to more accurately stage and better manage patients. In a clinical study, NETSPOT™ demonstrated the ability to change management decisions regarding patients in 71% of cases previously imaged with Octreoscan. Saving just one patient from futile surgery can improve the treatment experience overall and significantly reduce the cost of care by reducing repetitive, often frustrating, and limitless diagnostics. NETSPOT™ offers superior sensitivity and accuracy compared to previously available diagnostics for NET patients. Gallium PET/CT also allows for calculation of standardized uptake value, has less whole body radiation, and is performed in less time versus Octreoscan. Gallium PET/CT is more accurate for staging and superior to Octreoscan SPECT in the detection of overall number of lesions in the body as well as organs and bones. Use of NETSPOT changed patient treatment and management in 71% of patients due to greater specificity compared to Octreoscan. It is a form of octreotide, which binds to a receptor on many NETs called the Somatostatin Receptor. NETSPOT, the new tracer for Gallium 68-Dotatate scan, is the next generation of OCTREOSCAN. PET Imaging Institute of South Florida is proud to offer newly available NETSPOT (Gallium 68-Dotatate) scan: A novel PET/CT tracer for the detection of Neuro Endocrine Tumors (NETs)